SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice.

Richards, T; Breymann, C; Brookes, MJ; Lindgren, S; Macdougall, IC; McMahon, LP; Munro, MG; Nemeth, E; Rosano, GMC; Schiefke, I; et al. Richards, T; Breymann, C; Brookes, MJ; Lindgren, S; Macdougall, IC; McMahon, LP; Munro, MG; Nemeth, E; Rosano, GMC; Schiefke, I; Weiss, G (2021) Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice. Ann Med, 53 (1). pp. 274-285. ISSN 1365-2060 https://doi.org/10.1080/07853890.2020.1867323
SGUL Authors: Rosano, Giuseppe Massimo Claudio

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Iron deficiency is a common cause of morbidity and can arise as a consequence or complication from many diseases. The use of intravenous iron has increased significantly in the last decade, but concerns remain about indications and administration. Modern intravenous iron preparations can facilitate rapid iron repletion in one or two doses, both for absolute iron deficiency and, in the presence of inflammation, functional iron deficiency, where oral iron therapy is ineffective or has not worked. A multidisciplinary team of experts experienced in iron deficiency undertook a consensus review to support healthcare professionals with practical advice on managing iron deficiency in gastrointestinal, renal and cardiac disease, as well as; pregnancy, heavy menstrual bleeding, and surgery. We explain how intravenous iron may work where oral iron has not. We provide context on how and when intravenous iron should be administered, and informed opinion on potential benefits balanced with potential side-effects. We propose how intravenous iron side-effects can be anticipated in terms of what they may be and when they may occur. The aim of this consensus is to provide a practical basis for educating and preparing staff and patients on when and how iron infusions can be administered safely and efficiently. Key messages Iron deficiency treatment selection is driven by several factors, including the presence of inflammation, the time available for iron replenishment, and the anticipated risk of side-effects or intolerance. Intravenous iron preparations are indicated for the treatment of iron deficiency when oral preparations are ineffective or cannot be used, and therefore have applicability in a wide range of clinical contexts, including chronic inflammatory conditions, perioperative settings, and disorders associated with chronic blood loss. Adverse events occurring with intravenous iron can be anticipated according to when they typically occur, which provides a basis for educating and preparing staff and patients on how iron infusions can be administered safely and efficiently.

Item Type: Article
Additional Information: © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Anaemia, cardiovascular diseases, chronic, erythrocyte transfusion, inflammatory bowel diseases, infusions, intravenous, iron, iron-deficiency, menorrhagia, pregnancy complications, renal insufficiency, Administration, Intravenous, Administration, Oral, Clinical Decision-Making, Consensus, Female, Humans, Iron Compounds, Iron Deficiencies, Male, Practice Guidelines as Topic, Pregnancy, Humans, Iron Compounds, Administration, Oral, Consensus, Pregnancy, Female, Male, Practice Guidelines as Topic, Administration, Intravenous, Clinical Decision-Making, Iron Deficiencies, Anaemia, iron-deficiency, cardiovascular diseases, erythrocyte transfusion, inflammatory bowel diseases, infusions, intravenous, iron, menorrhagia, renal insufficiency, chronic, pregnancy complications, 11 Medical and Health Sciences, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Ann Med
ISSN: 1365-2060
Language: eng
Dates:
DateEvent
December 2021Published
10 January 2021Published Online
15 December 2020Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
10/104/06Department of HealthUNSPECIFIED
R01 DK107309NIDDK NIH HHSUNSPECIFIED
R01 HD096863NICHD NIH HHSUNSPECIFIED
PubMed ID: 33426933
Web of Science ID: WOS:000606604400001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114069
Publisher's version: https://doi.org/10.1080/07853890.2020.1867323

Actions (login required)

Edit Item Edit Item